Tag:
Myelodysplastic Syndromes
Latest Headlines
Latest Headlines
ChemGenex's omacetaxine wins orphan drug status
ChemGenex Pharmaceuticals' lead program--omacetaxine--has won the FDA's orphan drug designation for the treatment of Myelodysplastic Syndromes. While a coup for the company, Australia's Herald Sun
